Researchers have uncovered the mechanical properties of the nanoscale "thorns" that develop inside lithium-ion batteries, which can cause them to short circuit and die – or worse, such as ...

Eliana Merle Barclays Bank PLC, Research Division. Great. Good afternoon, everyone. I'm Ellie Merle, one of the biotech analysts here at Barclays. Very happy to have Ionis here wi ...

Ingram's Water & Air Equipment reports that water filtration systems improve water quality by removing harmful contaminants, enhancing health, taste, and environmental benefits.

Solid-state batteries could be safer and more energy-dense than today’s lithium-ion technology, but finding materials that allow ions to move quickly through solid electrolytes has been difficult.

BayWa r.e. is ready to unveil plans for its proposed 150-megawatt lithium-ion battery facility on the same Frank Sottile Boulevard property once considered for the controversial and ultimately ...

The MarketWatch News Department was not involved in the creation of this content. SAN DIEGO, Jan. 6, 2026 /PRNewswire/ -- HUYABIO International today announced favorable Phase 1 clinical data for ...

Iondrive (ASX: ION) has completed a Phase 1 evaluation for a 2,000-tonne-per-annum modular plant designed to recover rare earth elements from end-of-life permanent magnets, with results indicating ...

Ion exchange separates components in a sample depending on their relative ionic strengths and interaction with the stationary phase. The stationary phase is a charged substance that selectively ...

Walking barefoot along the beach, breathing in the salty air, and feeling the waves wash over your feet brings an unmistakable sense of calm and renewal. Somehow, our worries seem to fade with the ...

Abstract: We study the characteristics of small-amplitude nonlinear dust-ion-acoustic (DIA) solitary waves in active magnetized positive-ion-beam-driven dusty plasmas with the effects of nonadiabatic ...

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) ranks among the best biotech stocks to buy. On September 24, Leerink Partners maintained its Outperform rating on Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) ...